# Curative Study of Chinese Traditional Medicine to Treat Lung Cancer

> **NCT02777788** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Shanghai University of Traditional Chinese Medicine** · enrollment: 120 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** JinFuKang
- **DRUG:** XingZaoRuanJian
- **DRUG:** pemetrexed,docetaxel,gemcitabine,paclitaxel or vinorelbine combined with carboplatin、cis-platinum or nedaplatin

## Key facts

- **NCT ID:** NCT02777788
- **Lead sponsor:** Shanghai University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2017-10-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02777788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02777788, "Curative Study of Chinese Traditional Medicine to Treat Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02777788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*